Search
Search
About
Log in
Join
Experiences with
Sofosbuvir
Posts
Communities
68 public posts
Filter results
AASLD 2015: Sofosbuvir/ Velpatasvir + GS-9857 for 8 Weeks Cures Most Genotype 1 or 3 Hepatitis C Patients
http://hivandhepatitis.org/hcv-treatment/experimental-hcv-drugs/5476-aasld-2015-sofosbuvirvelpatasvir-gs-9857-for-8-weeks-cures-most-genotype-1-or-3-hepatitis-c-patients
http://hivandhepatitis.org/hcv-treatment/experimental-hcv-drugs/5476-aasld-2015-sofosbuvirvelpatasvir-gs-9857-for-8-weeks-cures-most-genotype-1-or-3-hepatitis-c-patients
kcohen
in
HFI Connect - Hepatitis
8 years ago
AASLD 2015: Sofosbuvir/ Velpatasvir Shows High Cure Rates for All HCV Genotypes in Phase 3 | Experimental HCV Drugs
http://hivandhepatitis.org/hcv-treatment/experimental-hcv-drugs/5479-aasld-2015-sofosbuvirvelpatasvir-shows-high-cure-rates-for-all-hcv-genotypes-in-phase-3
http://hivandhepatitis.org/hcv-treatment/experimental-hcv-drugs/5479-aasld-2015-sofosbuvirvelpatasvir-shows-high-cure-rates-for-all-hcv-genotypes-in-phase-3
kcohen
in
HFI Connect - Hepatitis
8 years ago
Ledipasvir/Sofosbuvir for the Treatment of Patients With Chronic Genotype 4 or 5 HCV Infection
http://natap.org/2015/EASL/EASL_80.htm
http://natap.org/2015/EASL/EASL_80.htm
kcohen
in
HFI Connect - Hepatitis
8 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Gilead's Sofosbuvir + Velpatasvir Combo Shows Good Results in Phase 3 Trials
http://hivandhepatitis.org/hcv-treatment/experimental-hcv-drugs/5392-gileads-
sofosbuvir
-velpatasvir-combo-shows-good-results-in-phase-3-trials
http://hivandhepatitis.org/hcv-treatment/experimental-hcv-drugs/5392-gileads-
sofosbuvir
-velpatasvir-combo-shows-good-results-in-phase-3-trials
kcohen
in
HFI Connect - Hepatitis
9 years ago
Achillion's Odalasvir with Sofosbuvir Cured Hepatitis C in 6-8 Weeks in Phase 2 Study
http://hivandhepatitis.org/hcv-treatment/experimental-hcv-drugs/5391-achillions-odalasvir-with-
sofosbuvir
-cured-hepatitis-c-in-6-8-weeks-in-phase-2-study
http://hivandhepatitis.org/hcv-treatment/experimental-hcv-drugs/5391-achillions-odalasvir-with-
sofosbuvir
-cured-hepatitis-c-in-6-8-weeks-in-phase-2-study
kcohen
in
HFI Connect - Hepatitis
9 years ago
Lack of Drug Interactions Between Boosted/Unboosted TAF-Based Antiretroviral & the anti-HCV Single-Tablet Regimens Ledipasvir/Sofosbuvir
http://www.natap.org/2015/IDSA/IDSA_11.htm
http://www.natap.org/2015/IDSA/IDSA_11.htm
kcohen
in
HFI Connect - Hepatitis
9 years ago
Ledipasvir/Sofosbuvir Is Safe and Effective for the Treatment of Patients with Genotype 1 Chronic HCV Infection in Both HCV Mono- and HIV/HC
http://www.natap.org/2015/IDSA/IDSA_13.htm
http://www.natap.org/2015/IDSA/IDSA_13.htm
kcohen
in
HFI Connect - Hepatitis
9 years ago
Gilead Submits NDA to U.S. FDA for Fixed-Dose Combination of Sofosbuvir/Velpatasvir for Treatment of All Six Genotypes of Hep C
http://hepatitiscnewdrugs.blogspot.com/2015/10/gilead-submits-nda-to-us-fda-for-fixed.html
http://hepatitiscnewdrugs.blogspot.com/2015/10/gilead-submits-nda-to-us-fda-for-fixed.html
kcohen
in
HFI Connect - Hepatitis
9 years ago
Veterans Affairs Gets $500M in Emergency Hepatitis C Funding
The new influx of VA funding, which was approved by both Congress and President Obama, can be used to cover Gilead Science’s Sovaldi (
sofosbuvir
) and Harvoni (ledipasvir/
sofosbuvir
) treatments, as well as AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir) for eligible veterans.
The new influx of VA funding, which was approved by both Congress and President Obama, can be used to cover Gilead Science’s Sovaldi (
sofosbuvir
) and Harvoni (ledipasvir/
sofosbuvir
) treatments, as well as AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir) for eligible veterans.
kcohen
in
HFI Connect - Hepatitis
9 years ago
State restrictions for hepatitis C drug may go too far
In 2013, the U.S. approved a new drug known as
sofosbuvir
, which is marketed here as Sovaldi by Gilead. Given in combination with other drugs,
sofosbuvir
achieves very high cure rates in patients with the difficult to treat infection.
In 2013, the U.S. approved a new drug known as
sofosbuvir
, which is marketed here as Sovaldi by Gilead. Given in combination with other drugs,
sofosbuvir
achieves very high cure rates in patients with the difficult to treat infection.
kcohen
in
HFI Connect - Hepatitis
9 years ago
State restrictions for hepatitis C drug may go too far
In 2013, the U.S. approved a new drug known as
sofosbuvir
, which is marketed here as Sovaldi by Gilead. Given in combination with other drugs,
sofosbuvir
achieves very high cure rates in patients with the difficult to treat infection.
In 2013, the U.S. approved a new drug known as
sofosbuvir
, which is marketed here as Sovaldi by Gilead. Given in combination with other drugs,
sofosbuvir
achieves very high cure rates in patients with the difficult to treat infection.
kcohen
in
HFI Connect - Hepatitis
9 years ago
Your role in hepatitis C treatment
The first new drug,
sofosbuvir
, earned FDA approval in late 2013 and carried a price tag of $84,000 for a course of treatment. “I wish drug companies would lower their prices. And they are starting to do that,” says Neil A.
The first new drug,
sofosbuvir
, earned FDA approval in late 2013 and carried a price tag of $84,000 for a course of treatment. “I wish drug companies would lower their prices. And they are starting to do that,” says Neil A.
kcohen
in
HFI Connect - Hepatitis
9 years ago
FDA OK’s BMS Daklinza (Daclatasvir) to Treat Hep C Genotype 3
Food and Drug Administration (FDA) has approved Bristol-Myers Squibb’s (BMS) NS5A inhibitor Daklinza (daclatasvir) to be used in combination with Gilead Sciences’ Sovaldi (
sofosbuvir
) to treat genotype 3 of hepatitis C.
Food and Drug Administration (FDA) has approved Bristol-Myers Squibb’s (BMS) NS5A inhibitor Daklinza (daclatasvir) to be used in combination with Gilead Sciences’ Sovaldi (
sofosbuvir
) to treat genotype 3 of hepatitis C.
kcohen
in
HFI Connect - Hepatitis
9 years ago
Concerns Over State Restrictions on New Hepatitis C Drugs
They found that 42 states have put some sort of restriction on Sovaldi (
sofosbuvir
) since it came out in 2013, which costs nearly $84,000 for a standard 12-week course of treatment.
They found that 42 states have put some sort of restriction on Sovaldi (
sofosbuvir
) since it came out in 2013, which costs nearly $84,000 for a standard 12-week course of treatment.
kcohen
in
HFI Connect - Hepatitis
9 years ago
WHO Adds New Hepatitis C Drugs to Essential Medicines List
Specifically, the WHO added
sofosbuvir
(brand name Sovaldi) to the guide, as well as simeprevir (Olysio), daclatasvir, ribavirin and the non-nucleoside polymerase inhibitor dasabuvir.
Specifically, the WHO added
sofosbuvir
(brand name Sovaldi) to the guide, as well as simeprevir (Olysio), daclatasvir, ribavirin and the non-nucleoside polymerase inhibitor dasabuvir.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
California could spend nearly $5 billion on HCV drugs over next year
The wholesale acquisition cost price of $117,000 is based on the following regimens: 8, 12 and 24 weeks of Harvoni (ledipasvir/
sofosbuvir
, Gilead Sciences) and 12 and 24 weeks of Sovaldi (
sofosbuvir
, Gilead Sciences) plus ribavirin.
The wholesale acquisition cost price of $117,000 is based on the following regimens: 8, 12 and 24 weeks of Harvoni (ledipasvir/
sofosbuvir
, Gilead Sciences) and 12 and 24 weeks of Sovaldi (
sofosbuvir
, Gilead Sciences) plus ribavirin.
kcohen
in
HFI Connect - Hepatitis
9 years ago
Achieving SVR can lessen economic impact of HCV, save $3 billion
The treatment of choice was Harvoni (ledipasvir/
sofosbuvir
, Gilead Sciences). Cost of total work hours lost per patient was calculated using publicly available country-specific data that included working hours per day, working days per year and labor costs.
The treatment of choice was Harvoni (ledipasvir/
sofosbuvir
, Gilead Sciences). Cost of total work hours lost per patient was calculated using publicly available country-specific data that included working hours per day, working days per year and labor costs.
kcohen
in
HFI Connect - Hepatitis
9 years ago
Patent for hepatitis C treatment would cut access for millions, groups say:
Similar filings against the company have already been made in India, Egypt and the European Union.With its attempts to hold exclusive rights to
sofosbuvir
, which the company has branded Sovaldi, Gilead was “abusing patent laws by claiming existing public knowledge as its own,” Priti Radhakrishnan, a
Similar filings against the company have already been made in India, Egypt and the European Union.With its attempts to hold exclusive rights to
sofosbuvir
, which the company has branded Sovaldi, Gilead was “abusing patent laws by claiming existing public knowledge as its own,” Priti Radhakrishnan, a
mwright
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
Included in the list are Gilead Sciences’ Sovaldi (
sofosbuvir
) and Harvoni (ledipasvir/
sofosbuvir
), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
Included in the list are Gilead Sciences’ Sovaldi (
sofosbuvir
) and Harvoni (ledipasvir/
sofosbuvir
), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Sofosbuvir/Daclatasvir Combination Effective in Hepatitis C Treatment - See more at: http://www.specialtypharmacytimes.com/news/Sofosbuvir-D
he combination of
sofosbuvir
and daclatasvir showed promising results for the treatment of hepatitis C virus (HCV) during a recent clinical trial, which was the first to evaluate this drug combination in a real world setting. - See more at: http://www.specialtypharmacytimes.com/news/
Sofosbuvir
-Daclatasvir-Combination-Effective-in-Hepatitis-C-Treatment
he combination of
sofosbuvir
and daclatasvir showed promising results for the treatment of hepatitis C virus (HCV) during a recent clinical trial, which was the first to evaluate this drug combination in a real world setting. - See more at: http://www.specialtypharmacytimes.com/news/
Sofosbuvir
-Daclatasvir-Combination-Effective-in-Hepatitis-C-Treatment
mwright
in
HFI Connect - Hepatitis
9 years ago
1
2
3
4
Next page
Filter results
Clear filters
Posted in
All communities
HFI Connect - Hepatitis
50 results
British Liver Trust
7 results
Hepatitis C Support
7 results
View top 10 communities
Sort by
Most Relevant
Newest